Status:
COMPLETED
Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
Infectious morbidity and mortality is a major complication of AML (Acute Myeloid Leukemia) induction and consolidation chemotherapies related aplasia. The main aim of this study is to measure incidenc...
Detailed Description
Bacterial and fungal infection treatment is well defined with guidelines. Few data are available for viral infections and concern essentially allogeneic stem cell transplantation. These infections are...
Eligibility Criteria
Inclusion
- Patients over 18 years old with an AML diagnostic and treated with induction and consolidation chemotherapy. Patients enrolled in another protocol may be included.
- Patients with relapsed leukemia who are treated with a salvage intensive therapy stay in the study
- Patients who have signed a consent policyholder
Exclusion
- patients under 18 years old
- patients treated with another treatment than induction and consolidation chemotherapy
- pregnant women
- patients HIV, HBV or HBC positive
- patients with a positive PCR at J1
- patients treated with an antiviral treatment or an immunosuppressive treatment for another pathology
- patients under guardianship
- Primitive immunity Deficit
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT01819792
Start Date
April 1 2013
End Date
July 1 2016
Last Update
April 23 2018
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Pr Marolleau
Amiens, France, 80054
2
CHU CAEN
Caen, France, 14000
3
Chru Lille
Lille, France, 59000
4
Chu Rouen
Rouen, France, 76000